关于帕金森病药物的前景的定性研究:来自患者焦点小组的见解
Kristin Richards1, Sneha Mantri2, Carolyn M Brown1
1TxCORE, College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA.
Patient preference and adherence
|September 23, 2024
概括
患有帕金森病的人 (PwPD) 经历药物有效性的不确定性,负担,副作用,并有特定的治疗要求. 加强医疗服务提供者与患者之间的沟通对于更好的结果至关重要.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 患者报告的结果
背景情况:
- 药物治疗是帕金森病 (PD) 管理的核心.
- 有限的研究探讨了患者对PD药物决策的观点.
研究的目的:
- 了解患有帕金森病 (PwPD) 的人的药物经验和观点.
主要方法:
- 定性研究涉及来自美国五家运动障碍诊所的32名PwPD.
- 在2022年进行1小时的在线聚焦小组.
- 采用专题分析来解释数据.
主要成果:
- 出现了四个主题:药物有效性 (不确定性,不一致性),药物负担 (剂量,时间),副作用 (耐受性,困惑性) 和患者对治疗进展的偏好.
- 据PwPD报道,有效性,每日疗程负担和副作用管理存在挑战.
- 患者表达了对特定药物特性和未来治疗改进的愿望.
结论:
- 从患者的角度来看,确定了PD药物的四个关键维度.
- 强调需要改善医疗服务提供者与患者之间的沟通,以解决药物不确定性和负担.
- 强调了加强沟通的潜力,以改善PwPD的健康结果.
相关概念视频
01:24Parkinson's Disease: Treatment
235
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
235
01:15Parkinson's Disease: Overview
495
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
495
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:26Psychosis: Goals of Pharmacotherapy
110
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
110
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
463
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
463
01:26Drug Administration and Therapy Phases: Overview
416
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
416